35 related articles for article (PubMed ID: 2157444)
1. Iron Dyshomeostasis in COVID-19: Biomarkers Reveal a Functional Link to 5-Lipoxygenase Activation.
Dufrusine B; Valentinuzzi S; Bibbò S; Damiani V; Lanuti P; Pieragostino D; Del Boccio P; D'Alessandro E; Rabottini A; Berghella A; Allocati N; Falasca K; Ucciferri C; Mucedola F; Di Perna M; Martino L; Vecchiet J; De Laurenzi V; Dainese E
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613462
[TBL] [Abstract][Full Text] [Related]
2. CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide.
Kast RE; Karpel-Massler G; Halatsch ME
Oncotarget; 2014 Sep; 5(18):8052-82. PubMed ID: 25211298
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory activity of a lipid fraction (lyprinol) from the NZ green-lipped mussel.
Whitehouse MW; Macrides TA; Kalafatis N; Betts WH; Haynes DR; Broadbent J
Inflammopharmacology; 1997; 5(3):237-46. PubMed ID: 17638133
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of release of vasoactive and inflammatory mediators in airway and vascular tissues and macrophages by a chinese herbal medicine formula for allergic rhinitis.
Lenon GB; Li CG; Xue CC; Thien FC; Story DF
Evid Based Complement Alternat Med; 2007 Jun; 4(2):209-17. PubMed ID: 17549238
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of release of inflammatory mediators in primary and cultured cells by a Chinese herbal medicine formula for allergic rhinitis.
Lenon GB; Xue CC; Story DF; Thien FC; McPhee S; Li CG
Chin Med; 2007 Feb; 2():2. PubMed ID: 17302969
[TBL] [Abstract][Full Text] [Related]
6. Potentiation and inhibition of migration of human neutrophils by auranofin.
Elferink JG; de Koster BM
Ann Rheum Dis; 1993 Aug; 52(8):595-8. PubMed ID: 8215623
[TBL] [Abstract][Full Text] [Related]
7. Auranofin and its combination with LTB4 influences ATP level and migration of human polymorphonuclear cells in vitro.
Partsch G; Matucci-Cerinic M
Inflammation; 1995 Jun; 19(3):277-88. PubMed ID: 7628859
[TBL] [Abstract][Full Text] [Related]
8. Enzymes involved in the biosynthesis of leukotriene B4.
Samuelsson B; Funk CD
J Biol Chem; 1989 Nov; 264(33):19469-72. PubMed ID: 2555321
[No Abstract] [Full Text] [Related]
9. Enzymes functional in the syntheses of leukotrienes and related compounds.
Shimizu T
Int J Biochem; 1988; 20(7):661-6. PubMed ID: 2846379
[TBL] [Abstract][Full Text] [Related]
10. Auranofin stimulates LTA hydrolase and inhibits 5-lipoxygenase/LTA synthase activity of isolated human neutrophils.
Betts WH; Hurst NP; Murphy GA; Cleland LG
Biochem Pharmacol; 1990 Apr; 39(7):1233-7. PubMed ID: 2157444
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of human neutrophil leukotriene B4 synthesis by combination auranofin and eicosapentaenoic acid.
James MJ; Cleland LG; Gibson RA
Biochem Pharmacol; 1992 Feb; 43(4):695-700. PubMed ID: 1311589
[TBL] [Abstract][Full Text] [Related]
12. Modulation of human neutrophil LTA hydrolase activity by phorbol myristate acetate.
McColl SR; Hurst NP; Betts WH; Cleland LG
Biochem Biophys Res Commun; 1987 Sep; 147(2):622-6. PubMed ID: 2820409
[TBL] [Abstract][Full Text] [Related]
13. Phorbol myristate acetate and the calcium ionophore A23187 synergistically induce release of LTB4 by human neutrophils: involvement of protein kinase C activation in regulation of the 5-lipoxygenase pathway.
Liles WC; Meier KE; Henderson WR
J Immunol; 1987 May; 138(10):3396-402. PubMed ID: 3033073
[TBL] [Abstract][Full Text] [Related]
14. Effect of auranofin on eicosanoids and protein kinase C in human neutrophils.
Herlin T; Fogh K; Christiansen NO; Kragballe K
Agents Actions; 1989 Aug; 28(1-2):121-9. PubMed ID: 2551149
[TBL] [Abstract][Full Text] [Related]
15. Metabolism of arachidonic acid through the 5-lipoxygenase pathway in normal human peritoneal macrophages.
Laviolette M; Carreau M; Coulombe R; Cloutier D; Dupont P; Rioux J; Braquet P; Borgeat P
J Immunol; 1988 Sep; 141(6):2104-9. PubMed ID: 2844895
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
